Found: 5
Select item for more details and to access through your institution.
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 428, p. 1, doi. 10.1126/scitranslmed.aaf7444
- By:
- Publication type:
- Article
HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically <sup>11</sup>C-Labeled Set-Tagged Affibody Molecule.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1446, doi. 10.2967/jnumed.111.102194
- By:
- Publication type:
- Article
Combining [<sup>11</sup>C]-AnxA5 PET Imaging with Serum Biomarkers for Improved Detection in Live Mice of Modest Cell Death in Human Solid Tumor Xenografts.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042151
- By:
- Publication type:
- Article
A method for comparing intra-tumoural radioactivity uptake heterogeneity in preclinical positron emission tomography studies.
- Published in:
- EJNMMI Physics, 2015, v. 2, n. 1, p. 1, doi. 10.1186/s40658-015-0124-1
- By:
- Publication type:
- Article
Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-016-0213-8
- By:
- Publication type:
- Article